Extract
What are the policy implications of use of epidemiological evidence in mass torts and public health litigation?
No longer available (Autolink)
See the full content of this document
This document cites
- Federal Cases - 830 F.2d 1190 (1st Cir. 1987), 86-2055, Lynch v. Merrell-National Laboratories, Div. of Richardson-Merrell, Inc.
- Federal Cases - 788 F.2d 741 (11th Cir. 1986), 85-8683, Wells v. Ortho Pharmaceutical Corp.
- Federal Cases - 78 F.3d 316 (7th Cir. 1996), 95-3064, Rosen v. Ciba-Geigy Corp.
- Federal Cases - 394 F.3d 594 (8th Cir. 2005), 03-3557, Boerner v. Brown & Williamson Tobacco Co.
- Federal Cases - 362 F.3d 882 (6th Cir. 2004), 02-3267, Tompkin v. Philip Morris USA, Inc.